Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chemokine C-C motif ligand 11 (CCL11), also known as eotaxin-1, is a small cytokine belonging to the CC chemokine family. It functions primarily as a chemoattractant for eosinophils, playing a crucial role in allergic responses and inflammation. CCL11 binds to CCR3, its primary receptor, which is highly expressed on eosinophils, inducing their migration and activation. It is produced by various cell types, including epithelial cells, fibroblasts, and immune cells, in response to inflammatory stimuli. Elevated levels of CCL11 are associated with several diseases, including asthma, aging-related cognitive decline, psychiatric disorders, and neurodegenerative conditions, making it a potential biomarker and therapeutic target.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine C-C motif ligand 11 (CCL11).